FDA Inspection 1102420 — Andre Lacroix, MD
The FDA completed an inspection of Andre Lacroix, MD on August 30, 2019 in Montreal. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 30, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Montreal (Canada)
Additional Details
Clinical Investigator (CI)